Ex parte MOHR et al. - Page 2



                 Appeal No. 2001-0400                                                                                     
                 Application No. 08/751,624                                                                               

                         Claims 1 and 16 are representative and read as follows:                                          
                         1.   A method for substantially completely inactivating viruses in a blood                       
                 product, comprising:                                                                                     
                         providing a blood bag comprising a transparent wall retaining said blood                         
                 product comprising said viruses;                                                                         
                         adding to said blood bag a phenothiazine dye in an amount sufficient to                          
                 produce a dye concentration in said blood product in the range of from about 0.5                         
                 µM to about 2 µM; and                                                                                    
                         irradiating said blood bag and said blood product comprising                                     
                 phenothiazine dye retained therein with visible light having a wavelength in the                         
                 range of the absorption peak of said phenothiazine dye, wherein said irradiation                         
                 passes through said transparent wall to said phenothiazine dye and continues for                         
                 a period of time sufficient to substantially completely inactivate said viruses.                         
                         16.  A method for removal of phenothiazine dye from a blood product, said                        
                 method comprising passing said blood product over an adsorbing agent which                               
                 strongly binds said phenothiazine and only weakly binds blood proteins, said                             
                 adsorbing agent being selected from the group consisting of silica gel,                                  
                 polystyrene-divinylbenzene, acrylic ester polymers having a pore size in the                             
                 range of from about 10Å to about 300 Å, and combinations thereof.                                        
                         The examiner relies on the following references:                                                 
                 Hodgson et al. (Hodgson)                    4,190,542            Feb. 26, 1980                           
                 Sugiyama et al. (Sugiyama)                  4,728,432            Mar.   1, 1988                          
                 Bio-Rad Catalog, “Chromatographic Supports,” Life Science Research Products,                             
                 pp. 11-12 (1993)                                                                                         
                 Heinmets et al. (Heinmets), “Inactivation of Viruses in Plasma by Photosensitized                        
                 Oxidation,” Department of Defense Research Report, WRAIR-53-55, pp. 1-16                                 
                 (1955)                                                                                                   
                         Claims 1-3, 5-16, 19-22, 24, and 27 stand rejected under 35 U.S.C. § 112,                        
                 first paragraph, as unsupported by an enabling disclosure.1                                              

                                                                                                                          
                 1 The Examiner’s Answer actually states that “[c]laims 1-3, 5-24, 26, 27 stand rejected under 35         
                 U.S.C. § 112, first paragraph.”  However, claims 17 and 18 were cancelled in an amendment filed          
                 June 15, 1998 (Paper No. 9).  This amendment was denied entry as an after-final amendment                

                                                            2                                                             



Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  Next 

Last modified: November 3, 2007